Article

Genome-wide association studies identify genetic determinants of synucleinopathy biomarkers

2025-12-30

Abstract excerpt

<h4>Objective</h4> α-synucleinopathies are clinically and biologically heterogeneous disorders lacking reliable biomarkers to assist with early diagnosis, disease progression, patient stratification, and therapeutic targeting. Genetic variation is known to impact biomarker levels, influencing their utility and interpretation in research and clinical settings. We aimed to identify common genetic modulators of biom...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2714c4e4-acbd-5524-8bfb-43c774e70d15
DOI: 10.64898/2025.12.29.25343142

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Genome-wide association studies identify genetic determinants of synucleinopathy biomarkersDOI 10.64898/2025.12.29.25343142Read

Genome-wide association studies identify genetic determinants of synucleinopathy biomarkers.Semantic proximity Read

Elucidate biomarkers and the molecular pathways associated with genetic variants that contribute to the etiology of Parkinson's disease.Semantic proximity Read

The <i>GBA1</i> p.E427K (p.E388K) Variant is a Risk Factor for Synucleinopathies: A Meta-AnalysisSemantic proximity Read

Stratified cohorts for biomarker assessment and trial readiness: <i>TMEM175</i> , <i>SCARB2</i> and <i>CTSB</i> in Parkinson’s diseaseSemantic proximity Read

Multi-omics insights into GBA1-associated Parkinson's disease: interplay of genomics, transcriptomics, proteomics, and lipidomics.Semantic proximity Read

Assessment of heterogeneity and disease onset in the Parkinson’s Progression Markers Initiative (PPMI) cohort using the α-synuclein seed amplification assay: a cross-sectional studySemantic proximity Read

A proteogenomic view of Parkinson’s disease causality and heterogeneitySemantic proximity Read

Parkinson’s disease causality and heterogeneity: a proteogenomic viewSemantic proximity Read

Parkinson’s disease causality and heterogeneity: a proteogenomic viewSemantic proximity Read

Large-scale Rare Variant Burden Testing in Parkinson’s Disease Identifies Novel Associations with Genes Involved in Neuro-inflammationSemantic proximity Read

Glucocerebrosidase activity and lipid levels are related to protein pathologies in Parkinson’s diseaseSemantic proximity Read

α-Synuclein Pathology in Synucleinopathies: Mechanisms, Biomarkers, and Therapeutic ChallengesSemantic proximity Read